Taro Pharmaceutical Industries Ltd. (TARO)

62.34 -0.43 (-0.69%) At close: 4:00PM EDT

Taro Pharmaceutical Industries Ltd.

14 Hakitor Street
Haifa Bay
Haifa 2624761
Israel
972 4 847 5700
http://www.taro.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 1,417

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Uday V. Baldota	CEO & Director	N/A	N/A	1970
Ms. Daphne Yan Huang	VP, CFO & Chief Accounting Officer	N/A	N/A	1971
Mr. Itamar Karsenti	VP & Head of Global Operations	N/A	N/A	1972
Mr. Avi Avramoff	VP and Head of R&D	N/A	N/A	1965
Mr. Itzik Baruch	VP of Technical Services	N/A	N/A	1963
Dr. Roman Kaplan Ph.D.	VP of Scientific and Technical Compliance Mang.	N/A	N/A	1947
Mr. William J. Coote	Assistant VP of Bus. Fin. & Investor Relations and Treasurer	N/A	N/A	1955
Mr. Erik Zwicker J.D.	VP, Gen. Counsel & Sec.	N/A	N/A	1980
Mr. Ara Aprahamian	VP of Sales & Marketing	616.14k	N/A	1968
Ms. Michele Visosky	VP & Head of Human Resource	N/A	N/A	1966

Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprises allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.

Corporate Governance

Taro Pharmaceutical Industries Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.